Sphingosine‐1‐phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin‐sensitive manner

No abstract is available for this paper.

• Publication year

  2000

• Venue

  British Journal of Pharmacology

• Publication date

  2000-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.bjp.0703516PMID 10952678PMCID PMC1572274
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sphingosine‐1‐phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro

  2000cited by this paper
• Sphingosine 1-phosphate induces sinus tachycardia and coronary vasoconstriction in the canine heart.

  2000cited by this paper
• Transduction of intracellular calcium signals through G protein-mediated activation of phospholipase C by recombinant sphingosine 1-phosphate receptors.

  1999cited by this paper
• Sphingosine-1-phosphate: extracellular mediator or intracellular second messenger?

  1999cited by this paper
• Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1.

  1999cited by this paper
• EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16.

  1999cited by this paper
• Dual Actions of Sphingosine-1-Phosphate: Extracellular through the Gi-coupled Receptor Edg-1 and Intracellular to Regulate Proliferation and Survival

  1998cited by this paper
• Depression of excitability by sphingosine 1-phosphate in rat ventricular myocytes.

  1998cited by this paper
• XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors.

  1998cited by this paper
• Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1‐phosphate

  1998cited by this paper
• Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1.

  1998cited by this paper
• Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum.

  1997influential reference
• Characterization of sphingosine 1-phosphate-induced actions and its signaling pathways in rat hepatocytes.

  1997cited by this paper
• Identification of cDNAs encoding two G protein‐coupled receptors for lysosphingolipids 1

  1997cited by this paper
• Distribution of sphingosine 1‐phosphate, a bioactive sphingolipid, in rat tissues

  1997influential reference
• Molecular diversity of sphingolipid signalling

  1997cited by this paper
• Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-α in the Adult Mammalian Cardiac Myocyte*

  1997cited by this paper
• Activation of a High Affinity G Protein-coupled Plasma Membrane Receptor by Sphingosine-1-phosphate (*)

  1996cited by this paper
• Sphingolipid actions on sodium and calcium currents of rat ventricular myocytes.

  1996cited by this paper
• Neuropeptide Y‐enhanced diuresis and natriuresis in anaesthetized rats is independent of renal blood flow reduction.

  1996cited by this paper
• Calcium signalling by G protein-coupled sphingolipid receptors in bovine aortic endothelial cells

  1996cited by this paper
• Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction

  1995cited by this paper
• Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets.

  1995cited by this paper
• Activation of muscarinic K+ current in guinea‐pig atrial myocytes by sphingosine‐1‐phosphate.

  1995cited by this paper
• Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphate-independent pathway.

  1994cited by this paper

• S1PR3 in hippocampal neurons improves synaptic plasticity and decreases depressive behavior via downregulation of RhoA/ROCK1.

  2025cites this paper
• Sphingolipid signaling in kidney diseases.

  2025cites this paper
• Application of sphingolipid-based nanocarriers in drug delivery: an overview.

  2024cites this paper
• Fingolimod, a sphingosine-1-phosphate agonist for the treatment of hepatopulmonary syndrome: Queries and concerns.

  2023cites this paper
• Metabolic profiling reveals new serum signatures to discriminate lupus nephritis from systemic lupus erythematosus

  2022cites this paper
• Mice brain metabolomics after the exposure to a "chemical cocktail" and selenium supplementation through the gut-brain axis.

  2022cites this paper
• Metabolomics Signature of Plasma Renin Activity and Linkage with Blood Pressure Response to Beta Blockers and Thiazide Diuretics in Hypertensive European American Patients

  2021cites this paper
• Metabolomics reveals sex-specific metabolic shifts and predicts the duration from positive to negative in non-severe COVID-19 patients during recovery process

  2021cites this paper
• Diuretic Effect and Metabolomics Analysis of Crude and Salt-Processed Plantaginis Semen

  2020cites this paper
• Sphingosine-1-phosphate receptor 3 in the medial prefrontal cortex promotes stress resilience by reducing inflammatory processes

  2019cites this paper
• Sphingosine-1-Phosphate Enhances α1-Adrenergic Vasoconstriction via S1P2–G12/13–ROCK Mediated Signaling

  2019cites this paper
• cAMP guided his way: a life for G protein-mediated signal transduction and molecular pharmacology—tribute to Karl H. Jakobs

  2019cites this paper
• Serum metabolic profile characteristics of offspring rats before and after birth caused by prenatal caffeine exposure.

  2019cites this paper
• Requirement for sphingosine kinase 1 in mediating phase 1 of the hypotensive response to anandamide in the anaesthetised mouse

  2019cites this paper
• Sphingosine-1-phosphate signaling in blood pressure regulation.

  2019cites this paper
• Nephrotoxicity of Natural Products: Aristolochic Acid and Fungal Toxins

  2017cites this paper
• Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget

  2017cites this paper
• Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics

  2017cites this paper
• S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis

  2016cites this paper
• Minireviews S 1 P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis

  2016cites this paper
• Implication of sphingosin-1-phosphate in cardiovascular regulation.

  2016cites this paper
• Decreased serum concentrations of sphingosine-1-phosphate in sepsis

  2015cites this paper
• MODELS, BIOLOGICAL Expression of Sphingosine-1-phosphate (S1P) on the cerebral vasospasm after subarachnoid hemorrhage in rabbits 1

  2015cites this paper
• Ceramides - Lipotoxic Inducers of Metabolic Disorders.

  2015cites this paper
• Inhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium Channel.

  2015cites this paper
• Expression of Sphingosine-1-phosphate (S1P) on the cerebral vasospasm after subarachnoid hemorrhage in rabbits.

  2015cites this paper
• Role of Ca2+ -dependent and Ca2+ -sensitive mechanisms in sphingosine 1-phosphate-induced constriction of isolated porcine retinal arterioles in vitro.

  2014cites this paper
• Sphingosine-1-phosphate evokes unique segment-specific vasoconstriction of the renal microvasculature.

  2014cites this paper
• Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor

  2014cites this paper
• Sphingosine 1-Phosphate in Renal Diseases

  2013cites this paper
• Aberrant Sphingolipid Metabolism in the Human Fallopian Tube with Ectopic Pregnancy

  2013cites this paper
• The therapeutic potential of nanoscale sphingolipid technologies.

  2013cites this paper
• Fumonisin Toxicity and Mechanism of Action: Overview and Current Perspectives

  2013cites this paper
• Sphingosine 1‐Phosphate (S1P) Signaling and the Vasculature

  2013cites this paper
• CHAPTER 15 Sphingosine 1-Phosphate ( S 1 P ) Signaling and the Vasculature

  2013cites this paper
• Role of sphingosine-1-phosphate inβ-adrenoceptor desensitization via Ca(2+) sensitization in airway smooth muscle.

  2012cites this paper
• Sphingosine-1-phosphate induced vasoconstriction is increased in the isolated perfused kidneys of diabetic rats.

  2011cites this paper
• Pharmacological relevance and potential of sphingosine 1‐phosphate in the vascular system

  2011cites this paper
• Role of sphingosine-1-phosphate in the renal medulla.

  2011cites this paper
• Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

  2011cites this paper
• S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate.

  2010cites this paper
• Relevance of sphingolipids in the pleiotropic protective effects of high-density lipoproteins.

  2010cites this paper
• S 1 P 2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate

  2010cites this paper
• Nephrotoxicity of Natural Products: Aristolochic Acid and Fungal Toxins

  2010cites this paper
• Stratification of Sphingosine Kinase-1 Expression and Activity in Rat Kidney

  2008cites this paper
• UNIVERSITY OF FLORIDA THESIS OR DISSERTATION FORMATTING TEMPLATE

  2008cites this paper
• Sphingolipid signalling in the cardiovascular system: good, bad or both?

  2008cites this paper
• Relevance and potential of sphingosine-1-phosphate in vascular inflammatory disease

  2008cites this paper
• Multifaceted roles of sphingosine‐1‐phosphate: How does this bioactive sphingolipid fit with acute neurological injury?

  2008cites this paper
• Cell-culture-dependent change of Ca2+ response of rat aortic myocytes to sphingosine-1-phosphate.

  2008cites this paper
• Analysis of sphingosine 1‐phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools

  2008cites this paper
• The multi-functional role of sphingosylphosphorylcholine.

  2008cites this paper
• Fumonisins : Toxicokinetics, mechanism of action and toxicity

  2007cites this paper
• Vascular effects of sphingolipids

  2007cites this paper
• Sphingosine‐1‐phosphate and FTY720 as anti‐atherosclerotic lipid compounds

  2007cites this paper
• Sphingosine 1‐Phosphate Mediates Proliferation and Survival of Mesoangioblasts

  2007cites this paper
• Sphingosine 1-Phosphate Causes Airway Hyper-Reactivity by Rho-Mediated Myosin Phosphatase Inactivation

  2007influential citation
• Toxicity of Fumonisins, Mycotoxins from Fusarium verticillioides

  2007cites this paper
• Vascular dysfunction in S1P2 sphingosine 1-phosphate receptor knockout mice.

  2007cites this paper
• Indomethacin differentiates the renal effects of sphingosine-1-phosphate and sphingosylphosphorylcholine

  2006cites this paper
• Sphingosine-1-Phosphate Acts via Rho-Associated Kinase and Nitric Oxide to Regulate Human Placental Vascular Tone1

  2006cites this paper
• Signal Transduction of Sphingosine-1-Phosphate G Protein—Coupled Receptors

  2006cites this paper
• Sphingosine 1-phosphate regulates cytoskeleton dynamics: implications in its biological response.

  2006cites this paper
• Vascular dysfunction in S 1 P 2 sphingosine 1-phosphate receptor knockout mice

  2006cites this paper
• Differential sensitivity of rat kidney and liver to fumonisin toxicity: organ-specific differences in toxin accumulation and sphingoid base metabolism.

  2006influential citation
• Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine

  2006influential citation
• A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome.

  2005cites this paper
• Effects of S1P on Myoblastic Cell Contraction: Possible Involvement of Ca2+-Independent Mechanisms

  2005cites this paper
• The role of sphingosine-1-phosphate in smooth muscle contraction.

  2005cites this paper
• Perspectives in Diabetes A Role for Sphingolipids in Producing the Common Features of Type 2 Diabetes , Metabolic Syndrome X , and Cushing ’ s Syndrome

  2005cites this paper
• Wirkungen der Lysophospholipide Sphingosin-1-Phosphat, Lysophosphatidsäure und Sphingosylphosphorylcholin auf Nierentubuluszellen des Opossums

  2005cites this paper
• Mechanisms of cardioprotection by lysophospholipids

  2004influential citation
• Sphingosine 1‐phosphate‐induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats

  2004cites this paper
• Cardiovascular effects of sphingosine‐1‐phosphate and other sphingomyelin metabolites

  2004cites this paper
• Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors.

  2004cites this paper
• Point-Counterpoint of Sphingosine 1-Phosphate Metabolism

  2004cites this paper
• Comparison of noradrenaline and lysosphingolipid-induced vasoconstriction in mouse and rat small mesenteric arteries.

  2004cites this paper
• Fluid Shear Stress Differentially Regulates gpr3, gpr6, and gpr12 Expression in Human Umbilical Vein Endothelial Cells

  2003cites this paper
• Induction of pro-angiogenic signaling by a synthetic peptide derived from the second intracellular loop of S1P3 (EDG3).

  2003cites this paper
• S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate.

  2003cites this paper
• Comparison of signalling mechanisms involved in rat mesenteric microvessel contraction by noradrenaline and sphingosylphosphorylcholine

  2003cites this paper
• Comparison of Sphingosine 1-Phosphate–Induced Intracellular Signaling Pathways in Vascular Smooth Muscles: Differential Role in Vasoconstriction

  2002cites this paper
• Sphingosylphosphorylcholine-biological functions and mechanisms of action.

  2002cites this paper
• Transient relaxation of rat mesenteric microvessels by ceramides

  2002cites this paper
• Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKCε knockout mouse hearts

  2002cites this paper
• Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts.

  2002cites this paper
• Sphingosine 1-phosphate signaling in atherosclerosis and vascular biology

  2002cites this paper
• Lysophospholipids and the cardiovascular system.

  2002cites this paper
• Nifedipine inhibits sphinogosine-1-phosphate-induced renovascular contraction in vitro and in vivo.

  2001cites this paper
• Nifedipine inhibits sphingosine-1-phosphate-induced renovascular contraction in vitro and in vivo

  2001cites this paper
• Lysosphingolipid receptor‐mediated diuresis and natriuresis in anaesthetized rats

  2001cites this paper
• Sphingosine 1-Phosphate Contracts Canine Basilar Arteries In Vitro and In Vivo: Possible Role in Pathogenesis of Cerebral Vasospasm

  2001cites this paper
• Sphingosine‐1‐phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro

  2000cites this paper
• Role of Sphingosine-1-phosphate in the Renal Medulla Editorial Focus

  year unknowncites this paper